Cargando…
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value
Treatment with the alkylating agent temozolomide is known to be prognostically beneficial in a subset of glioblastoma patients. Response to such chemotherapeutic treatment and the prognostic benefit have been linked to the methylation status of O(6)-methylguanine-DNA methyltransferase (MGMT). To dat...
Autores principales: | Leske, Henning, Camenisch Gross, Ulrike, Hofer, Silvia, Neidert, Marian Christoph, Leske, Sabine, Weller, Michael, Lehnick, Dirk, Rushing, Elisabeth Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463744/ https://www.ncbi.nlm.nih.gov/pubmed/37641156 http://dx.doi.org/10.1186/s40478-023-01622-w |
Ejemplares similares
-
CpGs relieve arthritis
por: Bashyam, Hema
Publicado: (2007) -
Thousands of CpGs Show DNA Methylation Differences in ACPA-Positive Individuals
por: Zeng, Yixiao, et al.
Publicado: (2021) -
Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR
por: Kagami, Masayo, et al.
Publicado: (2019) -
Sparse conserved under-methylated CpGs are associated with high-order chromatin structure
por: Lin, Xueqiu, et al.
Publicado: (2017) -
Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
por: Hubertus, Jochen, et al.
Publicado: (2013)